China Oncology Biosimilars Market Research Report 2018

Publisher Name :
Date: 07-Mar-2018
No. of pages: 97
Inquire Before Buying

The global Oncology Biosimilars market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Oncology Biosimilars development status and future trend in China, focuses on top players in China, also splits Oncology Biosimilars by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- Celltrion Inc.

- Pfizer Inc.

- Biocon

- BIOCAD

- Apotex Inc.

- Dr. Reddy's Laboratories Ltd.

- Sandoz International GmbH

- Intas Pharmaceuticals Ltd.

- STADA Arzneimittel AG

- Teva Pharmaceutical Industries Ltd.

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

- G-CSF

- Hematopoietic Agents

- Monoclonal Antibodies

On the basis of the end users/application, this report covers

- Retail Pharmacies

- Hospital Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

China Oncology Biosimilars Market Research Report 2018

Table of Contents
China Oncology Biosimilars Market Research Report 2018
1 Oncology Biosimilars Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars by Product Category
1.2.1 China Oncology Biosimilars Sales (MT) Comparison by Type (2013-2025)
1.2.2 China Oncology Biosimilars Sales (MT) Market Share by Type in 2017
1.2.3 G-CSF
1.2.4 Hematopoietic Agents
1.2.5 Monoclonal Antibodies
1.3 China Oncology Biosimilars Market by Application/End Users
1.3.1 China Oncology Biosimilars Sales (MT) and Market Share Comparison by Applications (2013-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 China Oncology Biosimilars Market by Region
1.4.1 China Oncology Biosimilars Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Oncology Biosimilars Status and Prospect (2013-2025)
1.4.3 East China Oncology Biosimilars Status and Prospect (2013-2025)
1.4.4 Southwest China Oncology Biosimilars Status and Prospect (2013-2025)
1.4.5 Northeast China Oncology Biosimilars Status and Prospect (2013-2025)
1.4.6 North China Oncology Biosimilars Status and Prospect (2013-2025)
1.4.7 Central China Oncology Biosimilars Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Oncology Biosimilars (2013-2025)
1.5.1 China Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2025)
1.5.2 China Oncology Biosimilars Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 China Oncology Biosimilars Market Competition by Players/Manufacturers
2.1 China Oncology Biosimilars Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Oncology Biosimilars Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Oncology Biosimilars Average Price (USD/Kg) by Players/Manufacturers (2013-2018)
2.4 China Oncology Biosimilars Market Competitive Situation and Trends
2.4.1 China Oncology Biosimilars Market Concentration Rate
2.4.2 China Oncology Biosimilars Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area, Product Types
3 China Oncology Biosimilars Sales and Revenue by Region (2013-2018)
3.1 China Oncology Biosimilars Sales (MT) and Market Share by Region (2013-2018)
3.2 China Oncology Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Oncology Biosimilars Price (USD/Kg) by Regions (2013-2018)
4 China Oncology Biosimilars Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Oncology Biosimilars Sales (MT) and Market Share by Type/ Product Category (2013-2018)
4.2 China Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Oncology Biosimilars Price (USD/Kg) by Type (2013-2018)
4.4 China Oncology Biosimilars Sales Growth Rate (%) by Type (2013-2018)
5 China Oncology Biosimilars Sales by Application (2013-2018)
5.1 China Oncology Biosimilars Sales (MT) and Market Share by Application (2013-2018)
5.2 China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 China Oncology Biosimilars Players/Suppliers Profiles and Sales Data
6.1 Celltrion Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oncology Biosimilars Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Pfizer Inc.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oncology Biosimilars Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Biocon
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oncology Biosimilars Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 BIOCAD
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oncology Biosimilars Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Apotex Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oncology Biosimilars Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Dr. Reddy's Laboratories Ltd.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oncology Biosimilars Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 Sandoz International GmbH
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oncology Biosimilars Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Intas Pharmaceuticals Ltd.
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oncology Biosimilars Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 STADA Arzneimittel AG
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oncology Biosimilars Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Teva Pharmaceutical Industries Ltd.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oncology Biosimilars Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview
7 Oncology Biosimilars Manufacturing Cost Analysis
7.1 Oncology Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Biosimilars
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncology Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Oncology Biosimilars Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Oncology Biosimilars Sales (MT), Revenue (Million USD) Forecast (2018-2025)
11.2 China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025)
11.3 China Oncology Biosimilars Sales (MT) Forecast by Application (2018-2025)
11.4 China Oncology Biosimilars Sales (MT) Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Oncology Biosimilars Sales (MT) and Revenue (Million USD) Market Split by Product Type
Table Oncology Biosimilars Sales (MT) by Application (2013-2025)
Figure Product Picture of Oncology Biosimilars
Table China Oncology Biosimilars Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Oncology Biosimilars Sales Volume Market Share by Types in 2017
Figure G-CSF Product Picture
Figure Hematopoietic Agents Product Picture
Figure Monoclonal Antibodies Product Picture
Figure China Oncology Biosimilars Sales (MT) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Oncology Biosimilars by Application in 2017
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure South China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2025)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Oncology Biosimilars Sales of Key Players/Manufacturers (2013-2018)
Table China Oncology Biosimilars Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Oncology Biosimilars Sales Share (%) by Players/Manufacturers
Figure 2017 China Oncology Biosimilars Sales Share (%) by Players/Manufacturers
Table China Oncology Biosimilars Revenue by Players/Manufacturers (2013-2018)
Table China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers
Table China Market Oncology Biosimilars Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Oncology Biosimilars Average Price of Key Players/Manufacturers in 2017
Figure China Oncology Biosimilars Market Share of Top 3 Players/Manufacturers
Figure China Oncology Biosimilars Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Oncology Biosimilars Product Category
Table China Oncology Biosimilars Sales (MT) by Regions (2013-2018)
Table China Oncology Biosimilars Sales Share (%) by Regions (2013-2018)
Figure China Oncology Biosimilars Sales Share (%) by Regions (2013-2018)
Figure China Oncology Biosimilars Sales Market Share (%) by Regions in 2017
Table China Oncology Biosimilars Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Oncology Biosimilars Revenue Market Share (%) by Regions (2013-2018)
Figure China Oncology Biosimilars Revenue Market Share (%) by Regions (2013-2018)
Figure China Oncology Biosimilars Revenue Market Share (%) by Regions in 2017
Table China Oncology Biosimilars Price (USD/Kg) by Regions (2013-2018)
Table China Oncology Biosimilars Sales (MT) by Type (2013-2018)
Table China Oncology Biosimilars Sales Share (%) by Type (2013-2018)
Figure China Oncology Biosimilars Sales Share (%) by Type (2013-2018)
Figure China Oncology Biosimilars Sales Market Share (%) by Type in 2017
Table China Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Oncology Biosimilars Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Oncology Biosimilars by Type (2013-2018)
Figure Revenue Market Share of Oncology Biosimilars by Type in 2017
Table China Oncology Biosimilars Price (USD/Kg) by Types (2013-2018)
Figure China Oncology Biosimilars Sales Growth Rate (%) by Type (2013-2018)
Table China Oncology Biosimilars Sales (MT) by Applications (2013-2018)
Table China Oncology Biosimilars Sales Market Share (%) by Applications (2013-2018)
Figure China Oncology Biosimilars Sales Market Share (%) by Application (2013-2018)
Figure China Oncology Biosimilars Sales Market Share (%) by Application in 2017
Table China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018)
Figure China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018)
Table Celltrion Inc. Oncology Biosimilars Basic Information List
Table Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Pfizer Inc. Oncology Biosimilars Basic Information List
Table Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Biocon Oncology Biosimilars Basic Information List
Table Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Biocon Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Biocon Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Biocon Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table BIOCAD Oncology Biosimilars Basic Information List
Table BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure BIOCAD Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure BIOCAD Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure BIOCAD Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Apotex Inc. Oncology Biosimilars Basic Information List
Table Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Apotex Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Apotex Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Apotex Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Basic Information List
Table Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Sandoz International GmbH Oncology Biosimilars Basic Information List
Table Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Basic Information List
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table STADA Arzneimittel AG Oncology Biosimilars Basic Information List
Table STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Basic Information List
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Players/Manufacturers in 2017
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure China Oncology Biosimilars Sales (MT) and Growth Rate (%) Forecast (2018-2025)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Oncology Biosimilars Price (USD/Kg) Trend Forecast (2018-2025)
Table China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025)
Figure China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025)
Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Type in 2025
Table China Oncology Biosimilars Sales (MT) Forecast by Application (2018-2025)
Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Application in 2025
Table China Oncology Biosimilars Sales (MT) Forecast by Regions (2018-2025)
Table China Oncology Biosimilars Sales Volume Share Forecast by Regions (2018-2025)
Figure China Oncology Biosimilars Sales Volume Share Forecast by Regions (2018-2025)
Figure China Oncology Biosimilars Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Biosimilar Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Drug Market 2018, Forecast to 2023
    Published: 10-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Jun-2018        Price: US 3480 Onwards        Pages: 154
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023
    Published: 09-Jun-2018        Price: US 4880 Onwards        Pages: 150
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global and China Adalimumab Biosimilar Market Research by Company, Type & Application 2013-2025
    Published: 25-May-2018        Price: US 2000 Onwards        Pages: 78
    Summary Market Segment as follows: By Type - Tablet - Oral Solution By Application - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy By Company - AET BioTech - Amgen - Boehringer Ingelheim - Coherus Biosciences - Fujifilm Kyowa Kirin Biologics - LG Life Sciences/Mochida Pharmaceutical - Momenta Pharmaceuticals - Oncobiologics - Pfize......
  • United States Biosimilar Monoclonal Antibodies Market Report 2018
    Published: 23-May-2018        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Biosimilar Monoclonal Antibodies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Biosimilar Monoclonal Antibodies Market Research Report 2018
    Published: 18-May-2018        Price: US 2900 Onwards        Pages: 110
    This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Biosimilar Monoclonal Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of ......
  • Global Oncology Biosimilars Market Data Survey Report 2025
    Published: 22-Apr-2018        Price: US 1500 Onwards        Pages: 80
    Summary The global Oncology Biosimilars market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity......
  • Global and United States Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 120
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs